IOL Chemicals & Pharmaceuticals Ltd

IOL Chemicals & Pharmaceuticals Ltd

Next 500 2024
+ 6 More
+ 6 More
OVERVIEW
FINANCIALS

Featured In Fortune India Ranking

Fortune 500 India
#495(2021)
#500(2020)
#495(2021)#500(2020)
Ranking Trend Fortune 500 India
Next 500 India
#195(2024)#68(2023)#102(2020)#295(2019)#436(2018)
#195(2024)#68(2023)#102(2020)#295(2019)#436(2018)
Ranking Trend Fortune Next 500 India

Financial Data 2024

Revenue
2,201
(INR Cr)
Net Operating Income
2,133
(INR Cr)
Assets
1,651
(INR Cr)
Profit
134
(INR Cr)
Net Worth
1,612
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Revenue
(INR Cr)
2201
-2.7%
2261
-0.3%
2268
12.9%
2008
6.3%
1890
14.9%
1644
80.4%
911
24.7%
731
21.2%
603
47.9%
408
-31.2%
593
14.4%
518
4.0%
498
18.3%
421
17.5%
358
12.4%
319
-
Net Operating Income
(INR Cr)
2133
-3.80%
2217
1.52%
2184
0.00%
1967
3.83%
1894
12.41%
1685
71.40%
983
38.37%
711
22.44%
580
50.87%
385
-31.73%
564
17.03%
482
2.30%
471
20.87%
389
11.44%
349
15.76%
302
-5.06%
Profit
(INR Cr)
134
-3.4%
139
-17.0%
168
-62.3%
445
23.1%
361
52.6%
237
754.5%
28
493.2%
5
-
-40
-
-67
-
3
107.6%
2
-66.6%
5
-23.0%
6
-38.3%
10
-21.0%
13
-
Assets
(INR Cr)
1651
3.9%
1589
10.4%
1439
13.6%
1267
44.4%
877
14.9%
764
13.8%
671
2.9%
652
1.9%
640
3.9%
616
4.6%
589
-2.1%
602
4.3%
577
12.2%
514
23.3%
417
16.4%
359
-
Net Worth
(INR Cr)
1612
6.9%
1508
8.3%
1392
0.0%
1260
54.9%
814
71.5%
474
119.9%
216
14.3%
189
1.9%
185
-10.7%
207
9.5%
189
12.7%
168
-0.4%
169
0.8%
167
16.9%
143
34.4%
107
61.6%
Employee Cost
(INR Cr)
201
19.5%
168
19.0%
141
22.3%
116
18.9%
97
23.9%
78
39.8%
56
29.9%
43
22.9%
35
42.1%
25
-8.7%
27
22.6%
22
9.6%
20
22.7%
16
45.9%
11
38.2%
8
-
Interest Cost
(INR Cr)
161686215164686159605743371515
Cash & Bank Balance
(INR Cr)
143221403651553017171213111291877
Total Debt
(INR Cr)
338044359284422447453400357400394337269247

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Profit As % Of Revenues 6.1%6.2%7.4%22.1%19.1%14.4%3.0%0.6%--0.6%0.3%1.0%1.5%2.8%4.0%
Profit As % Of Assets 8.1%8.8%11.7%35.1%41.2%31.0%4.1%0.7%--0.6%0.3%0.8%1.2%2.4%3.5%
Profit As % Of Networth 8.3%9.2%12.0%35.3%44.4%49.9%12.8%2.5%--1.7%1.0%2.8%3.7%7.0%11.9%
Interest Cost to EBITDA % 7.0%7.3%3.4%1.0%3.7%12.6%53.8%66.2%119.6%525.0%63.0%64.3%63.0%54.4%38.6%45.7%
Debt to Equity Ratio 0.020.050.030.000.070.601.962.372.441.931.892.382.342.021.882.32
RONW 8.6%9.6%12.0%42.9%56.1%66.0%11.4%2.2%--1.9%0.9%2.8%4.0%8.0%14.7%
ROCE 12.2%13.5%16.2%53.8%67.5%53.0%13.6%10.9%0.0%0.0%11.0%10.2%8.6%9.8%7.6%9.6%